EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Promising new drugs and drug targets for HIV treatment

Sarah Duncan, Lucy Dorrell

Future Prescriber · 2013

DOI: 10.1002/fps.108 ↗
AstrattDettalji biblijografiċi

Astratt

Abstract The mortality associated with HIV has declined since the introduction of combination antiretroviral therapy (cART) and life expectancy for those who begin treatment early enough is now approaching that of the general population. However, key concerns in maintaining long‐term control of HIV are side‐effects and convenience/adherence. This review will discuss the available and recently introduced treatments, and the potential future therapies currently under investigation.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →